1. Алиев М.Д., Сушенцов Е.А. Современная онкоортопедия. Саркомы костей, мягких тканей и опухоли кожи. 2012.- №4. - сс3-10.
2. Алиев М.Д.. Злокачественные опухоли костей Саркомы костей, мягких тканей и опухоли кожи. 2010.- №2. - сс3-8
3. Алиев М.Д.. Эндопротезирование как основа онкоортопедии Саркомы костей, мягких тканей и опухоли кожи. 2010.- №4. - сс7-12
4. А.А.Курильчик, А.Л. Зубарев, Г.Т. Кудрявцева, А.Л. Стародубцев. Интраоперационная лучевая терапия (ИОЛТ) в комбинированном лечении остеосаркомы. Саркомы костей, мягких тканей и опухоли кожи. 2010.- №3. - сс30-33
5. Тепляков В.В., Карпенко В.Ю., Бухаров А.В., Державин В.А., Урлова А.Н., Рубцова Н.А.. Результаты хирургического лечения пациентов с метастазами в длинные трубчатые кости. Саркомы костей, мягких тканей и опухоли кожи. 2010.-№3. -cclO-15
6. Malawer M.M., Helman L.J., O’Sullivan B. Sarcomas of bone. / DeVita, Hellman, and Rosenberg"s Cancer: Principles & Practice of Oncology. - 2008. - 8th ed. - vol.2. -pp.1794-1833
7. Kalra S1, Grimer RJ, Spooner D. et al. Radiation-induced sarcomas of bone: factors that affect outcome. J Bone Joint Surg Br. 2007 Jun;89(6):808-13.
8. Grier HE, Krailo MD, Tarbell NJ, et al. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing"s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 2003;348:694-701.
9. Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007;99:112-128
10. Womer RB, West DC, Krailo MD, et al. Randomized controlled trial of interval-compressed chemotherapy for the treatment of localized Ewing sarcoma: A report from the Children’s Oncology Group. J Clin Oncol 2Ol2 Nov 2O;3O(33):4l48-54
11. Souhami RL, Craft AW, Van der Eijken JW, et al. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup. Lancet 1997;350:911-917.
12. Lewis IJ, Nooij MA, Whelan J, et al. Improvement in histologic response but not survival in osteosarcoma patients treated with intensi ed chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup. J Natl Cancer Inst 2007;99:112-128
13. Fiorenza F, Abudu A, Grimer RJ, et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br 2002;84:93-99
14. Marulanda GA, Henderson ER, Johnson DA, et al. Orthopedic surgery options for the treatment of primary osteosarcoma. Cancer Control 2008;15:13-20.
15. Bacci G, Ferrari S, Lari S, et al. Osteosarcoma of the limb. Amputation or limb salvage in patients treated by neoadjuvant chemotherapy. J Bone Joint Surg Br 2002;84:88-92.
16. Kager Ll, Zoubek A, Potschger U. et al. Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol. 2003 May 15;21(10):2011-8.
17. Gogna A1, Peh WC, Munk PL. Image-guided musculoskeletal biopsy. Radiol Clin North Am. 2008 May;46(3):455-73
18. Gupta AA1, Pappo A, Saunders N. et al. Clinical outcome of children and adults with localized Ewing sarcoma: impact of chemotherapy dose and timing of local therapy. Cancer. 2010 Jul 1;116(13):3189-94
19. Bacci G1, Forni C, Longhi A, Ferrari S. et al. Long-term outcome for patients with nonmetastatic Ewing"s sarcoma treated with adjuvant and neoadjuvant chemotherapies. 402 patients treated at Rizzoli between 1972 and 1992. Eur J Cancer. 2004 Jan;40(1):73-83.
20. Bielack SS1, Kempf-Bielack B, Delling G. et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol. 2002 Feb 1;20(3):776-90.
21. Bernthal NM1, Federman N, Eilber FR. et al. Long-term results (>25 years) of a randomized, prospective clinical trial evaluating chemotherapy in patients with highgrade, operable osteosarcoma. Cancer. 2012 Dec 1;118(23):5888-93.
22. Smeland S1, Bruland OS, Hjorth L. et al. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum follow-up of 4 years. Acta Orthop. 2011 Apr;82(2):211-6